Advertisement
Screener

TRANSCODE THERAPEUTICS, INC. (RNAZ) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent

TRANSCODE THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent

TRANSCODE THERAPEUTICS, INC. (RNAZ) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -4.40% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-04-15

  • TRANSCODE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -4.40%, a 393.33% decline from fiscal 2023.
  • TRANSCODE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 1.50%.
  • TRANSCODE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.10%.
  • TRANSCODE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -3.20%.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month
2024-12-31-4.40%
10-K · filed 2025-04-15
2023-12-311.50%
10-K · filed 2025-04-15
2022-12-31-0.10%
10-K · filed 2024-04-01
2021-12-31-3.20%
10-K · filed 2023-03-31
2020-12-31-14.80%
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87